Furthermore, a study among morbidly obese females undergoing bariatric surgery did not show any association between pathological features of NASH and plasma FGF-21, which suggests that body fat and gender, as well as other comorbidities, may modify this association [44]. This evidence concerns the gene FGF21 and metabolic dysfunction-associated steatohepatitis.